SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate HRT, FXNC, CBNK, DOMA
SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate HRT, FXNC, CBNK, DOMA
PR Newswire
NEW YORK, April 1, 2024
NEW YORK, April 1, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
HireRight Holdings Corporation (NYSE: HRT)'s sale to affiliates of General Atlantic, L.P. and Stone Point Capital LLC for $14.35 per share in cash. If you are a HireRight shareholder, click here to learn more about your rights and options.
First National Corporation (NASDAQ: FXNC)'s merger with Touchstone Bankshares, Inc. Under the terms of the proposed transaction, Touchstone shareholders will receive 0.8122 shares of First National stock for each share of Touchstone stock. If you are a First National shareholder, click here to learn more about your rights and options.
Capital Bancorp, Inc. (NASDAQ: CBNK)'s merger with Integrated Financial Holdings, Inc. Per the terms of the proposed transaction, Integrated shareholders will, subject to certain adjustments, receive $5.36 in cash and 1.115 shares of Capital common stock for each share of Integrated common stock. If you are a Capital shareholder, click here to learn more about your rights and options.
Doma Holdings, Inc. (NYSE: DOMA)'s sale to Title Resources Group for $6.29 per share. If you are a Doma shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-halper-sadeh-llc-continues-to-investigate-hrt-fxnc-cbnk-doma-302105034.html
SOURCE Halper Sadeh LLP
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure